FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma

FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma

Objective: Multiple myeloma is an incurable hematological malignancy. It is imperative to identify immune markers for early diagnosis and therapy. Here, this study analyzed immune-related mRNAs and assessed their prognostic value and therapeutic potential.Methods: Abnormally expressed immune-related...

Full description

Bibliographic Details
Main Authors: Haipeng Jia, Xiaofen Zhang, Xinxin Liu, Ruifang Qiao, Yan Liu, Sulong Lv, Hongbo Zhu, Jie Wang, Qiuhong Kong, Hong Zhang, Zhirong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
multiple myeloma
FABP5
immunotherapy
prognosis
therapeutic target
immune microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.667525/full

Similar Items

Similar Items